Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
42.29
Dollar change
-1.06
Percentage change
-2.45
%
IndexRUT P/E- EPS (ttm)-0.01 Insider Own0.90% Shs Outstand48.60M Perf Week-4.71%
Market Cap2.06B Forward P/E89.46 EPS next Y0.47 Insider Trans-39.31% Shs Float48.16M Perf Month-14.41%
Income0.45M PEG- EPS next Q-0.10 Inst Own105.03% Short Float10.02% Perf Quarter-4.45%
Sales207.78M P/S9.89 EPS this Y222.83% Inst Trans-2.04% Short Ratio12.04 Perf Half Y18.83%
Book/sh4.82 P/B8.77 EPS next Y449.76% ROA0.15% Short Interest4.83M Perf Year25.64%
Cash/sh2.44 P/C17.35 EPS next 5Y- ROE0.21% 52W Range30.18 - 53.05 Perf YTD18.76%
Dividend Est.- P/FCF1007.50 EPS past 5Y19.85% ROI0.14% 52W High-20.28% Beta1.70
Dividend TTM- Quick Ratio4.83 Sales past 5Y17.25% Gross Margin69.50% 52W Low40.13% ATR (14)1.86
Dividend Ex-Date- Current Ratio5.20 EPS Y/Y TTM102.65% Oper. Margin-1.81% RSI (14)32.77 Volatility4.13% 4.07%
Employees314 Debt/Eq0.39 Sales Y/Y TTM22.72% Profit Margin0.22% Recom1.00 Target Price55.50
Option/ShortYes / Yes LT Debt/Eq0.37 EPS Q/Q49.30% Payout- Rel Volume0.96 Prev Close43.35
Sales Surprise4.51% EPS Surprise27.40% Sales Q/Q25.02% EarningsMay 08 BMO Avg Volume400.88K Price42.29
SMA20-9.91% SMA50-10.74% SMA2003.51% Trades Volume386,831 Change-2.45%
Date Action Analyst Rating Change Price Target Change
Jan-25-24Upgrade Truist Hold → Buy $39 → $51
Aug-08-23Upgrade BTIG Research Neutral → Buy $39
Nov-10-22Downgrade BTIG Research Buy → Neutral
Nov-09-22Downgrade Truist Buy → Hold
Oct-14-22Resumed Stephens Overweight $40
Jan-11-21Downgrade Oppenheimer Outperform → Perform
Dec-18-20Initiated Stephens Overweight $31
Sep-17-20Initiated Truist Buy $24
Oct-09-19Initiated H.C. Wainwright Buy $19
Feb-28-19Downgrade Needham Buy → Hold
Jun-11-24 08:30AM
May-22-24 08:30AM
May-21-24 06:42AM
May-09-24 03:28PM
03:08AM
11:24PM Loading…
May-08-24 11:24PM
09:35AM
09:10AM
07:55AM
Apr-24-24 08:30AM
Mar-29-24 07:01PM
Mar-28-24 01:48PM
Mar-15-24 07:00PM
Mar-01-24 09:30AM
Feb-29-24 11:37PM
09:05AM Loading…
09:05AM
08:32AM
07:55AM
Feb-27-24 08:30AM
Feb-22-24 12:00PM
Feb-18-24 03:00AM
Feb-15-24 10:00AM
08:50AM
08:30AM
Feb-05-24 08:30AM
Jan-30-24 11:01PM
08:50AM
Jan-25-24 09:49AM
Jan-24-24 07:01PM
Jan-19-24 08:28PM
08:47AM Loading…
Jan-09-24 08:47AM
07:55AM
Jan-03-24 08:30AM
Dec-17-23 03:01AM
Dec-09-23 03:05AM
Dec-02-23 05:04AM
Nov-23-23 07:04AM
Nov-16-23 05:35PM
Nov-10-23 09:52PM
Nov-09-23 03:56PM
Nov-08-23 03:30PM
07:55AM
Nov-07-23 08:30AM
Nov-01-23 10:01AM
Oct-25-23 08:30AM
Oct-24-23 01:22AM
Oct-23-23 05:59PM
Oct-16-23 10:23AM
Sep-28-23 08:30AM
Sep-20-23 04:30PM
Sep-06-23 08:30AM
Aug-10-23 01:48AM
Aug-02-23 09:05AM
07:55AM
Jul-23-23 11:44AM
Jul-20-23 08:30AM
Jul-10-23 09:30AM
Jun-21-23 08:00PM
May-10-23 09:05AM
07:55AM
May-02-23 09:00AM
Apr-26-23 08:00PM
08:30AM
Apr-24-23 02:06AM
Apr-17-23 03:03PM
Feb-28-23 08:30AM
Feb-23-23 09:45AM
07:55AM
Feb-09-23 08:00AM
Jan-31-23 07:19AM
Jan-11-23 10:24PM
Jan-10-23 07:55AM
Jan-04-23 08:34AM
Dec-30-22 01:42PM
05:26AM
Dec-29-22 01:46PM
01:45PM
Nov-11-22 06:09AM
Nov-10-22 09:00AM
Nov-09-22 09:05AM
07:55AM
Oct-26-22 08:30AM
Oct-10-22 11:50AM
Sep-22-22 08:30AM
Sep-06-22 08:30AM
Aug-09-22 09:55AM
Aug-04-22 04:30AM
Aug-03-22 09:05AM
07:55AM
07:30AM
Jul-21-22 04:05PM
Jul-20-22 08:30AM
Jul-08-22 08:30AM
Jun-30-22 10:50AM
May-04-22 08:30PM
09:05AM
07:55AM
Apr-20-22 08:30AM
Apr-09-22 08:07AM
Mar-15-22 08:30AM
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Colangelo DominickPresident and CEOJun 13 '24Option Exercise3.0217,50052,850238,252Jun 14 04:05 PM
Colangelo DominickPresident and CEOJun 13 '24Sale43.1017,500754,250220,752Jun 14 04:05 PM
Colangelo DominickPresident and CEOJun 12 '24Option Exercise3.0217,50052,850238,252Jun 14 04:05 PM
Colangelo DominickPresident and CEOJun 12 '24Sale44.1217,500772,100220,752Jun 14 04:05 PM
Hopper Jonathan MarkChief Medical OfficerMay 20 '24Option Exercise10.9510,000109,50068,116May 21 04:07 PM
Hopper Jonathan MarkChief Medical OfficerMay 20 '24Sale49.9910,000499,90058,116May 21 04:07 PM
Halpin MichaelChief Operating OfficerMay 17 '24Option Exercise5.395,19528,0176,284May 21 04:05 PM
Colangelo DominickPresident and CEOMay 16 '24Option Exercise3.0217,50052,850238,252May 17 04:05 PM
Colangelo DominickPresident and CEOMay 16 '24Sale47.8517,500837,375220,752May 17 04:05 PM
Colangelo DominickPresident and CEOMay 15 '24Option Exercise3.0217,50052,850238,252May 17 04:05 PM
Colangelo DominickPresident and CEOMay 15 '24Sale49.6717,500869,225220,752May 17 04:05 PM
Colangelo DominickPresident and CEOApr 30 '24Option Exercise11.7925,445299,977220,752May 01 04:05 PM
Colangelo DominickPresident and CEOApr 18 '24Option Exercise3.0217,50052,850212,807Apr 19 04:05 PM
Colangelo DominickPresident and CEOApr 18 '24Sale44.5917,500780,325195,307Apr 19 04:05 PM
Colangelo DominickPresident and CEOApr 17 '24Option Exercise3.0217,50052,850212,807Apr 19 04:05 PM
Colangelo DominickPresident and CEOApr 17 '24Sale46.4717,500813,225195,307Apr 19 04:05 PM
Rubino Alan LDirectorApr 09 '24Option Exercise4.123,00012,36020,594Apr 11 04:05 PM
ZERBE ROBERT L MDDirectorMar 27 '24Option Exercise3.743,27812,26026,673Mar 29 04:05 PM
ZERBE ROBERT L MDDirectorMar 27 '24Sale51.573,278169,04623,395Mar 29 04:05 PM
Colangelo DominickPresident and CEOMar 14 '24Option Exercise3.0217,50052,850212,370Mar 15 04:07 PM
Colangelo DominickPresident and CEOMar 14 '24Sale44.0217,500770,350194,870Mar 15 04:07 PM
Colangelo DominickPresident and CEOMar 13 '24Option Exercise3.0217,50052,850212,370Mar 15 04:07 PM
Colangelo DominickPresident and CEOMar 13 '24Sale44.6717,500781,725194,870Mar 15 04:07 PM
Halpin MichaelChief Operating OfficerMar 11 '24Sale44.717,874352,047949Mar 13 04:05 PM
Flynn Sean C.SVP, General CounselMar 08 '24Sale45.338,115367,853167Mar 11 04:07 PM
SIEGAL JONATHANPrincipal Accounting OfficerMar 07 '24Sale45.001,63473,5301,400Mar 11 04:08 PM
ZERBE ROBERT L MDDirectorFeb 20 '24Option Exercise3.747222,70024,117Feb 22 04:07 PM
Hopper Jonathan MarkChief Medical OfficerFeb 20 '24Option Exercise0.007,075058,695Feb 22 04:06 PM
SIEGAL JONATHANPrincipal Accounting OfficerFeb 20 '24Option Exercise0.002,92003,900Feb 22 04:06 PM
Mara Joseph Anthony JrChief Financial OfficerFeb 20 '24Option Exercise0.007,380020,097Feb 22 04:06 PM
Colangelo DominickPresident and CEOFeb 20 '24Option Exercise0.0038,8870199,013Feb 22 04:06 PM
Flynn Sean C.SVP, General CounselFeb 20 '24Option Exercise0.007,07509,059Feb 22 04:07 PM
Halpin MichaelChief Operating OfficerFeb 20 '24Option Exercise0.0011,887010,155Feb 22 04:07 PM
ZERBE ROBERT L MDDirectorFeb 20 '24Sale50.0172236,10723,395Feb 22 04:07 PM
Colangelo DominickPresident and CEOFeb 15 '24Option Exercise3.0217,50052,850191,508Feb 16 04:05 PM
Colangelo DominickPresident and CEOFeb 15 '24Sale48.8517,500854,875174,008Feb 16 04:05 PM
Colangelo DominickPresident and CEOFeb 14 '24Option Exercise3.0217,50052,850191,508Feb 16 04:05 PM
Colangelo DominickPresident and CEOFeb 14 '24Sale46.9917,500822,325174,008Feb 16 04:05 PM
Colangelo DominickPresident and CEOFeb 12 '24Option Exercise0.007,5000177,485Feb 13 04:05 PM
Halpin MichaelChief Operating OfficerFeb 12 '24Option Exercise0.003,50004,449Feb 13 04:05 PM
Hopper Jonathan MarkChief Medical OfficerFeb 12 '24Option Exercise0.001,625054,759Feb 13 04:06 PM
ZERBE ROBERT L MDDirectorJan 29 '24Sale44.222,300101,70623,395Jan 30 04:05 PM
ZERBE ROBERT L MDDirectorJan 25 '24Sale44.022008,80425,695Jan 29 04:05 PM
ZERBE ROBERT L MDDirectorJan 22 '24Option Exercise4.123,00012,36028,895Jan 24 04:05 PM
ZERBE ROBERT L MDDirectorJan 22 '24Sale41.858,000334,77525,895Jan 24 04:05 PM
Colangelo DominickPresident and CEOJan 18 '24Option Exercise3.0216,72650,513186,711Jan 19 04:06 PM
Colangelo DominickPresident and CEOJan 18 '24Sale38.5816,726645,289169,985Jan 19 04:06 PM
Colangelo DominickPresident and CEOJan 17 '24Option Exercise3.0216,72650,513186,711Jan 19 04:06 PM
Colangelo DominickPresident and CEOJan 17 '24Sale37.9716,726635,086169,985Jan 19 04:06 PM
ZERBE ROBERT L MDDirectorJan 12 '24Sale38.092,20083,79830,895Jan 16 04:05 PM
Colangelo DominickPresident and CEODec 14 '23Option Exercise3.5712,00042,840181,985Dec 15 04:05 PM
Colangelo DominickPresident and CEODec 14 '23Sale37.1212,000445,440169,985Dec 15 04:05 PM
Wotton Paul KDirectorDec 14 '23Sale37.315,000186,55026,802Dec 15 04:07 PM
Flynn Sean C.SVP, General CounselDec 14 '23Sale37.451063,9704,467Dec 15 04:07 PM
Colangelo DominickPresident and CEODec 13 '23Option Exercise3.5712,00042,840181,985Dec 15 04:05 PM
Colangelo DominickPresident and CEODec 13 '23Sale34.0312,000408,360169,985Dec 15 04:05 PM
Flynn Sean C.SVP, General CounselDec 13 '23Sale34.201,43248,9744,573Dec 15 04:07 PM
Colangelo DominickPresident and CEODec 07 '23Option Exercise3.5712,00042,840188,742Dec 08 04:05 PM
Colangelo DominickPresident and CEODec 07 '23Sale33.8412,000406,080176,742Dec 08 04:05 PM
Colangelo DominickPresident and CEODec 06 '23Option Exercise3.5712,39744,257189,139Dec 08 04:05 PM
Colangelo DominickPresident and CEODec 06 '23Sale34.4312,397426,829176,742Dec 08 04:05 PM
Halpin MichaelChief Operating OfficerNov 30 '23Option Exercise7.2017,447125,61818,274Dec 01 04:05 PM
Halpin MichaelChief Operating OfficerNov 30 '23Sale35.4117,447617,798827Dec 01 04:05 PM
Hopper Jonathan MarkChief Medical OfficerNov 20 '23Option Exercise10.955,00054,75058,007Nov 22 04:05 PM
Hopper Jonathan MarkChief Medical OfficerNov 20 '23Sale36.405,000182,00053,007Nov 22 04:05 PM
SIEGAL JONATHANPrincipal Accounting OfficerNov 15 '23Sale37.7066224,9541,305Nov 17 04:06 PM
ZERBE ROBERT L MDDirectorNov 15 '23Sale38.0230011,40633,095Nov 17 04:06 PM
SIEGAL JONATHANPrincipal Accounting OfficerOct 02 '23Option Exercise0.0093802,134Oct 04 04:05 PM
ZERBE ROBERT L MDDirectorJul 14 '23Sale38.841,00038,84033,395Jul 17 04:05 PM
ZERBE ROBERT L MDDirectorJun 22 '23Sale36.003,000108,00034,395Jun 26 04:05 PM